Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Gilead Sciences Inc | 109 |
| 2 | Clearside Biomedical Inc | 67 |
| 3 | Senju Pharmaceutical Co Ltd | 58 |
| 4 | Institució Catalana de Recerca i Estudis Avançats | 43 |
| 5 | University of Virginia | 37 |
| 6 | Roche Holding AG | 26 |
| 7 | Rohto Pharmaceutical Co Ltd | 23 |
| 8 | Alcon Inc | 21 |
| 9 | Ascendis Pharma AS | 21 |
| 10 | Kala Bio Inc | 20 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 969 |
| 2 | A61P | Therapeutic activity (drug indications) | 890 |
| 3 | C07K | Peptides | 244 |
| 4 | C07D | Heterocyclic compounds | 218 |
| 5 | G01N | Investigating / analysing materials | 162 |
| 6 | C12Q | Measuring/testing involving enzymes | 125 |
| 7 | A61M | Devices for introducing media into the body | 94 |
| 8 | A61F | 85 | |
| 9 | C07C | Acyclic and carbocyclic compounds | 85 |
| 10 | C12N | Microorganisms, enzymes | 62 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Gel for eye containing bromfenac sodium hydrate and preparation thereof | 2008 | 6 | |
| Bromfenac sodium hydrate eye drops and preparation method thereof | 2013 | 4 | |
| A kind of pharmaceutical aqueous eye drops and preparation method thereof containing bromfenac sodium hydrate | 2018 | 3 | |
| A kind of bromfenac sodium hydrate thermosensitive type situ-gel eye drop and preparation method thereof | 2016 | 3 | |
| Gel for eye containing bromfenac sodium hydrate and preparation thereof | 2013 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 7 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | James A. Gow | Spectrum Pharmaceuticals (United States) | 7 |
| 2 | Sheryl DeCleene | Women's Health Research Institute | 6 |
| 3 | L. David Waterbury | Emergent BioSolutions (Canada) | 6 |
| 4 | Frank A. Bucci | Bucci Laser Vision Institute | 5 |
| 5 | Joan Korth‐Bradley | Women's Health Research Institute | 5 |
| 6 | William H. Cevallos | Women's Health Research Institute | 4 |
| 7 | Timothy R. McNamara | Spectrum Pharmaceuticals (United States) | 4 |
| 8 | Joseph Boni | Women's Health Research Institute | 3 |
| 9 | Najam A. Sharif | Alcon (United States) | 3 |
| 10 | Hiroshi Fujishima | Tsurumi University | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Drug-Induced Hepatotoxicity | 2003 | 1586 | Pharmacogenetics and Drug Metabolism |
| The Safety of Newly Approved Medicines | 1999 | 241 | Pharmaceutical Economics and Policy |
| European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1 | 2018 | 159 | Retinal Diseases and Treatments |
| Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium | 2006 | 111 | Synthesis and biological activity |
| A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data | 1994 | 109 | Computational Drug Discovery Methods |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Bromfenac sodium hydrate?
Which organizations hold the most patents for Bromfenac sodium hydrate?
What is the trend in patent activity for Bromfenac sodium hydrate over recent years?
What formulation types of Bromfenac sodium hydrate have been patented?
What research topics are associated with published papers on Bromfenac sodium hydrate?